These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6324818

  • 1. 1-(4-Aminophenyl)isoquinoline derivatives. Potent inhibitors of calcium-independent and calcium-dependent phosphodiesterases from rat cerebral cortex.
    Davis CW, Walker KA.
    Biochem Pharmacol; 1984 Apr 15; 33(8):1205-12. PubMed ID: 6324818
    [Abstract] [Full Text] [Related]

  • 2. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
    Walker KA, Boots MR, Stubbins JF, Rogers ME, Davis CW.
    J Med Chem; 1983 Feb 15; 26(2):174-81. PubMed ID: 6298424
    [Abstract] [Full Text] [Related]

  • 3. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW.
    Biochim Biophys Acta; 1982 Jul 12; 705(1):1-7. PubMed ID: 6288105
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B, Ruckstuhl M, Landry Y.
    J Pharmacol; 1982 Jul 12; 13(2):307-16. PubMed ID: 6285085
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS, Rhoads AR.
    Biochem Pharmacol; 1982 Mar 01; 31(5):665-9. PubMed ID: 6177320
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of various phosphodiesterase inhibitors, pyrimidine and purine compounds, and inorganic phosphates on cyclic CMP, cyclic AMP and cyclic GMP phosphodiesterases.
    Helfman DM, Kuo JF.
    Biochem Pharmacol; 1982 Jan 01; 31(1):43-7. PubMed ID: 6277336
    [Abstract] [Full Text] [Related]

  • 12. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
    Butt NM, Saeed SA, Collier HO.
    Biochem Soc Trans; 1980 Jun 01; 8(3):380-1. PubMed ID: 6249674
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations.
    Hunt NH, Evans T.
    Biochim Biophys Acta; 1980 Jun 13; 613(2):499-506. PubMed ID: 6256001
    [Abstract] [Full Text] [Related]

  • 19. Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.
    Frossard N, Landry Y, Pauli G, Ruckstuhl M.
    Br J Pharmacol; 1981 Aug 13; 73(4):933-8. PubMed ID: 6168323
    [Abstract] [Full Text] [Related]

  • 20. The identification of apparently novel cyclic AMP and cyclic GMP phosphodiesterase activities in guinea-pig tracheal smooth muscle.
    Burns F, Stevens PA, Pyne NJ.
    Br J Pharmacol; 1994 Sep 13; 113(1):3-4. PubMed ID: 7812625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.